TerrAscend (TSNDF) Other Non-Current Assets (2021 - 2026)
TerrAscend's (TSNDF) quarterly Other Non-Current Assets came in at $5.2 million in Q1 2026, up 3002.98% year-on-year from $168000.0 in Q1 2025, and up 8588.33% on a QoQ basis from $60000.0 in Q4 2025.
TerrAscend (TSNDF) Other Non-Current Assets (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Other Non-Current Assets data on file, last reported at $5.2 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 3002.98% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 3002.98% increase from a year earlier, with the FY2025 full-year figure at $60000.0, down 91.7% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $5.2 million, up from $60000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for TSNDF reached as high as $5.2 million in Q1 2026 and fell as low as $60000.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $724000.0 in 2024.
- Across the five-year window, Other Non-Current Assets tumbled 91.7% in 2025 and soared 3002.98% in 2026, its largest moves.
- Year by year, Other Non-Current Assets stood at $837000.0 in 2022, then gained by 2.03% to $854000.0 in 2023, then dropped by 15.34% to $723000.0 in 2024, then tumbled by 91.7% to $60000.0 in 2025, then surged by 8588.33% to $5.2 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $5.2 million in Q1 2026, $60000.0 in Q4 2025, and $168000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 5.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.21 Mn |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 507,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 723,000.00 |
| Sep 30, 2024 | 284,000.00 |
| Jun 30, 2024 | 724,000.00 |
| Mar 31, 2024 | 867,000.00 |
| Dec 31, 2023 | 854,000.00 |
| Sep 30, 2023 | 426,000.00 |
| Jun 30, 2023 | 848,000.00 |
| Mar 31, 2023 | 525,000.00 |
| Dec 31, 2022 | 837,000.00 |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 4.82 Mn |
| Dec 31, 2021 | 3.14 Mn |